Anticoagulation in Device-Detected Atrial Fibrillation—Uncertainty and Heterogeneity in Value - Top-Institutions - MDSpire

Anticoagulation in Device-Detected Atrial Fibrillation—Uncertainty and Heterogeneity in Value

  • By

  • Hanxuan Yu

  • Jinyi Zhu

  • June 8, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    European Society of Cardiology
    European Society of Cardiology

    Brussels, Belgium

    Key Differentiators

    • Cardiology

  • #2

    JAMA Network Open
    JAMA Network Open

    Chicago, Illinois

    Key Differentiators

    • Cardiology

  • #3

    ARTESiA trial
    ARTESiA trial

    N/A, N/A

    Key Differentiators

    • Cardiology

  • #4

    NOAH-AFNET 6 trial
    NOAH-AFNET 6 trial

    N/A, N/A

    Key Differentiators

    • Cardiology

Original Source(s)

Anticoagulation in Device-Detected Atrial Fibrillation—Uncertainty and Heterogeneity in Value

  • by Hanxuan Yu, Jinyi Zhu

  • June 8, 2026

Related Content

Impact of frailty on post-procedural adverse outcomes in older adults aged ≥75 years undergoing percutaneous coronary intervention: a systematic review of observational studies

Advancing Stroke Care: WashU Medicine Specialists at Barnes-Jewish Hospital Help Chronic Stroke Patients with Innovative Use of Vagus Nerve Stimulation

For years, chronic stroke patients heard familiar feedback regarding their ability to regain strength and mobility after ischemic strokes caused upper-extremity deficits.

  • May 6, 2026

  • 7 min
Cardiac intimal sarcoma presenting as basilar artery occlusion treated with tenecteplase and thrombectomy: a case report